Immediate Impact
2 by Nobel laureates 54 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Printable molecule-selective core–shell nanoparticles for wearable and implantable sensing
2025 Standout
Works of Ying Lin being referenced
Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma
2014
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ying Lin | 343 | 347 | 234 | 23 | 586 | |
| Wilma J. Teubel | 254 | 313 | 158 | 17 | 556 | |
| Ryosuke Satomi | 321 | 253 | 188 | 17 | 544 | |
| Katherine R. Singleton | 492 | 189 | 134 | 16 | 643 | |
| Leila Dardaei | 321 | 338 | 155 | 13 | 607 | |
| Wei Wu | 322 | 288 | 282 | 32 | 662 | |
| Emily K. Slotkin | 215 | 257 | 129 | 38 | 520 | |
| Michaela A. Ihle | 306 | 278 | 177 | 23 | 652 | |
| Μαρία Κάρλου | 279 | 472 | 206 | 19 | 727 | |
| J. Baselga | 306 | 137 | 184 | 25 | 638 | |
| Riitta Mäkitaro | 226 | 199 | 162 | 14 | 522 |
All Works
Login with ORCID to disown or claim papers
Loading papers...